Prevalence and outcomes of vascular cognitive impairment

Neurology

Volumn 54, Issue 2, 2000, Pages 447-451

  Rockwood, Kenneth ^a   Wentzel, C ^a   Hachinski, V ^b   Hogan, D B ^c   MacKnight, C ^a   McDowell, I ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c QEII Health Sciences Centre ^*

Author keywords

Dementia; Diagnosis; Vascular cognitive impairment

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; FEMALE; HOSPITALIZATION; HUMAN; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0034711699     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.2.447     Document Type: Article

References (34)

1. Hachinski V. Vascular dementia: a radical redefinition. Dementia 1994;5:130-132.
2. Rockwood K. Lessons from mixed dementia. Int Psychogeriatr 1997;9:245-249.
3. Rockwood K, Parhad I, Hachinski V, et al. Diagnosis of vascular dementia: Consortium of Canadian Centres for Clinical Cognitive Research Consensus Statement. Can J Neurol Sci 1994;21:358-364.
4. Bowler JV, Eliasziw M, Steenhuis R, et al. Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia. Arch Neurol 1997;54:697-703.
5. Verhey FRJ, Lodder J, Rozendaal N, Jolles J. Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 1996;15:166-172.
6. Amar K, Wilcock GK, Scott M. The diagnosis of vascular dementia in the light of the new criteria. Age Ageing 1996;25: 51-55.
7. Wetterling T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia: ADDTC, DSM-IV, ICD-10, NINDS-AIREN. Stroke 1996;27:30-36.
8. Gold G, Giannakopoulos P, Montes-Paixao C, et al. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997;49:690-694.
9. Hulette C, Nochlin D, McKeel D, et al. Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology 1997;48:668-672.
10. Nolan KA, Lino MM, Seligmann AW, Blass JP. Absence of vascular dementia in an autopsy series from a dementia clinic. J Am Geriatr Soc 1998;46:597-604.
11. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997;63:749-753.
12. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA Markesbery WR. Brain infarction and the clinical expression of AD. JAMA 1997:277:813-817.
13. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, et al. Cerebral infarcts in patients with autopsy-proven AD (CERAD, part XVIII). Neurology 1998;51:159-162.
14. Nagy Z, Esiri MM, Jobst KA, et al. The effects of additional pathology on the cognitive deficit in AD. J Neuropathol Exp Neurol 1997;56:165-170.
15. Hachinski V. Preventable senility: a call for action against the vascular dementias. Lancet 1992;340:645-648.
16. Hachinski V, Bowler JV. Vascular dementia: diagnostic criteria for research studies. Neurology 1993;43:2159-2160.
17. Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. CMAJ 1994;150:899-913.
18. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793-1796.
19. Rockwood K, Ebly E, Hachinski V, Hogan D. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol 1997;54:33-39.
20. Graham JE, Rockwood K, Beattie BL, McDowell I, Eastwood R, Gauthier S. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology 1996;15:246-256.
21. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry 1987;48:314-318.
22. Kristjansson B, Hill G, McDowell I, Lindsay J Optimal cutpoints when screening for more than one disease state: an example from the Canadian Study of Health and Aging. J Clin Epidemiol 1996;49:1423-1428.
23. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1988;149:698-709.
24. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the non-demented elderly: results from the Canadian Study of Health and Aging. Arch Neurol 1995;52:612-619.
25. Rockwood K, Howard K, MacKnight C, Darvesh S. Spectrum of disease in vascular cognitive impairment. Neuroepidemiology 1999;18:248-254.
26. Hennekens CH, Buring JE. Epidemiology in Medicine. Boston: Little, Brown and Co., 1987.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, edn. 3, revised. Washington, DC, American Psychiatric Association, 1987.
28. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10). Geneva: World Health Organization, 1992:25-31.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadian EM. Clinical diagnosis of AD: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on AD. Neurology 1984;34:939-944.
30. Aevarsson O, Svanborg A, Skoog I. Seven-year survival after age 85: relation to AD and vascular dementia. Arch Neurol 1998;55:121-129.
31. Mölsä PK, Marttila RJ, Rinne UK. Long-term survival and predictors of mortality in AD and multi-infarct dementia. Acta Neurol Scand 1995;91:159-164.
32. Hachinski VC. The decline and resurgence of vascular dementia. CMAJ 1990;142:107-111.
33. Meyer JS, Rogers RL, McClintic K, Mortel KF, Lotfi J. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. J Am Geriatr Soc 1989;37:549-555.
34. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-1352.